AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $322,000 | -19.7% | 9,349 | -61.0% | 0.00% | -33.3% |
| Q2 2020 | $401,000 | +13.0% | 23,989 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $355,000 | -51.3% | 24,593 | +13.0% | 0.00% | -40.0% |
| Q4 2019 | $729,000 | +33.8% | 21,767 | -16.4% | 0.01% | +25.0% |
| Q3 2019 | $545,000 | +84.1% | 26,044 | +83.2% | 0.00% | +100.0% |
| Q2 2019 | $296,000 | +11.7% | 14,220 | +46.3% | 0.00% | 0.0% |
| Q3 2018 | $265,000 | -33.1% | 9,720 | -34.0% | 0.00% | -50.0% |
| Q2 2018 | $396,000 | +7.9% | 14,720 | +27.8% | 0.00% | 0.0% |
| Q1 2018 | $367,000 | +38.5% | 11,520 | +64.1% | 0.00% | +33.3% |
| Q4 2017 | $265,000 | – | 7,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLP GROUP LLC | 2,904,185 | $43,563,000 | 46.00% |
| Foresite Capital Management II, LLC | 3,967,900 | $59,519,000 | 28.42% |
| Aisling Capital LLC | 2,990,000 | $44,850,000 | 9.24% |
| Foresite Capital Management III, LLC | 935,020 | $14,025,000 | 6.56% |
| Vivo Capital, LLC | 763,009 | $11,445,000 | 3.57% |
| RA Capital Management | 1,292,940 | $19,394,000 | 2.00% |
| Palo Alto Investors LP | 379,727 | $5,696,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 418,214 | $6,273,000 | 0.32% |
| EMERALD ADVISERS, LLC | 464,364 | $6,965,000 | 0.31% |
| Rock Springs Capital Management LP | 293,000 | $4,395,000 | 0.28% |